Jason H. Williams
Arkansas Children's Hospital(US)Exelixis (United States)(US)Pfizer (United States)(US)BioCryst Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
RNA Interference and Gene Delivery, Advanced biosensing and bioanalysis techniques, Muscle Physiology and Disorders, Monoclonal and Polyclonal Antibodies Research, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Polymersome delivery of siRNA and antisense oligonucleotides(2008)182 cited
- → Bosutinib versus Placebo for Autosomal Dominant Polycystic Kidney Disease(2017)74 cited
- → Outcomes and Complications Related to the Management of Bosniak Cystic Renal Lesions(2015)60 cited
- → A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma(2020)59 cited
- → Induction of Dystrophin Expression by Exon Skipping in mdx Mice Following Intramuscular Injection of Antisense Oligonucleotides Complexed with PEG–PEI Copolymers(2006)38 cited
- → Functionalized PEG–PEI Copolymers Complexed to Exon-Skipping Oligonucleotides Improve Dystrophin Expression in mdx Mice(2008)38 cited